Xueqing Yu
Overview
Explore the profile of Xueqing Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
353
Citations
6669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Xie Y, Wang Y, Wu L, Yu X, Bai L, et al.
Complement Ther Med
. 2025 Feb;
89:103146.
PMID: 39956529
Background: Chronic obstructive pulmonary disease (COPD) is a common and frequently occurring disease that seriously endangers health, causing a heavy economic burden on patients and society. Acupuncture has been reported...
2.
Ma X, Li Z, Zhang L, Qian H, Chen Q, Tao Y, et al.
J Transl Med
. 2025 Feb;
23(1):144.
PMID: 39894850
Introduction: Anemia is a prevalent complication of chronic kidney disease (CKD), primarily due to insufficient erythropoietin (EPO). Pegmolesatide (by Hansoh Pharma) is currently the only marketed long-acting EPO mimetic peptide...
3.
Li M, Hao X, Shi D, Cheng S, Zhong Z, Cai L, et al.
Front Med
. 2024 Dec;
18(6):1119.
PMID: 39693015
No abstract available.
4.
Chen S, Fan L, Qiu Y, Chen N, Chen J, Liu Z, et al.
J Ren Nutr
. 2024 Dec;
PMID: 39653157
Objectives: Evidence of the effects of ketoanalogue supplements on residual kidney function (RKF) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) is limited. This study aimed to evaluate the efficacy...
5.
Kam-Tao Li P, Ng J, Cai G, Chen W, Chow K, Fan S, et al.
Kidney Dis (Basel)
. 2024 Oct;
10(5):384-397.
PMID: 39430291
Background: Chronic kidney disease (CKD) continues to be a significant global public health issue. The escalating burden of CKD is probably driven by the aging population and the rising prevalence...
6.
Zhong Y, Wei B, Wang W, Chen J, Wu W, Liang L, et al.
Int J Biol Sci
. 2024 Oct;
20(13):5027-5042.
PMID: 39430238
Fibrosis is characterized by the aberrant deposition of extracellular matrix (ECM) due to dysregulated tissue repair responses, imposing a significant global burden on fibrosis-related diseases. Although alpha-smooth muscle actin (α-SMA/)-expressing...
7.
Li M, Hao X, Shi D, Cheng S, Zhong Z, Cai L, et al.
Front Med
. 2024 Sep;
18(5):862-877.
PMID: 39343836
Although many susceptibility loci for IgA nephropathy (IgAN) have been identified, they only account for 11.0% of the overall IgAN variance. We performed a large genome-wide meta-analysis of IgAN in...
8.
Lei H, Yu X, Fan D
Adv Sci (Weinh)
. 2024 Sep;
11(42):e2405924.
PMID: 39269428
Current skin sensors or wound dressings fall short in addressing the complexities and challenges encountered in real-world scenarios, lacking adequate capability to facilitate wound repair. The advancement of methodologies enabling...
9.
Ye Z, Fan L, Yan R, Liu B, Zhou L, Xing G, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2579-2580.
PMID: 39156167
[This corrects the article DOI: 10.1016/j.ekir.2024.02.771.].
10.
Liang X, Lu W, Yu X, Cheng H, He Q, Peng Q, et al.
Clin Ther
. 2024 Aug;
46(9):702-710.
PMID: 39112102
Purpose: Sodium zirconium cyclosilicate (SZC) is an oral potassium (K)-lowering therapy for adults with hyperkalemia. HARMONIZE Asia (ClinicalTrials.gov identifier: NCT03528681) evaluated the efficacy and safety of SZC in Chinese patients...